ADIL vs AFRM · $6.0M cap vs P/E 590, rev $4.26B
Adial Pharmaceuticals Inc (ADIL) versus Affirm Holdings Inc (AFRM) — a side-by-side from cached financials, not a winner call.
Adial Pharmaceuticals Inc (ADIL) is a biotechnology company listed on NASDAQ.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
ADIL does not have a complete income-statement cache yet.
Latest reported AFRM revenue for 2026-06-30 was $4.26B. Net income was $1.93B. Revenue was up 32.2% from 2025-06-30 to 2026-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
ADIL currently screens at market cap $6.0M. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Not investment advice. Open the ADIL and AFRM stock pages for the full models.
Not investment advice.